Current Topics in Oncology

Download All
Experts discuss the optimal use of VEGF-targeted tyrosine kinase inhibitors for patients with GI malignancies in this this podcast series that includes downloadable summary slidesets.
Nilofer S. Azad, MD
Chiara Cremolini, MD, PhD
Joleen Hubbard, MD
person default
Teresa Macarulla, MD
John L. Marshall, MD
Kanwal Raghav, MD
person default
Rachel Riechelmann, MD, PhD

A Focus on VEGF TKIs

Listen to Joleen Hubbard, MD, and John L. Marshall, MD, discuss the use of key later-line treatment options for patients with mCRC, including optimal treatment sequencing and dosing and key adverse events.

Joleen Hubbard, MD John L. Marshall, MD Released: April 29, 2021

Download this slideset for key insights from our podcast featuring an expert discussion of the use of key later-line treatment options for patients with mCRC, including optimal treatment sequencing and dosing and how adverse events influence therapy decisions.

Joleen Hubbard, MD John L. Marshall, MD Released: April 29, 2021

Listen to Kanwal Raghav, MD, and Rachel Riechelmann, MD, PhD, as they provide their clinical insights into dosing of key later-line treatment options for patients with mCRC.

Kanwal Raghav, MD person default Rachel Riechelmann, MD, PhD Released: October 21, 2021

Download this slideset for key insights from a podcast featuring an expert discussion of dosing of key later-line treatment options for patients with mCRC.

Kanwal Raghav, MD person default Rachel Riechelmann, MD, PhD Released: October 21, 2021

Listen to Chiara Cremolini, MD, PhD, and Teresa Macarulla, MD, as they discuss the clinical data that inform how they select later-line treatment for patients with mCRC.

Chiara Cremolini, MD, PhD person default Teresa Macarulla, MD Released: December 17, 2021

Download this slideset for key insights from a podcast featuring an expert discussion of clinical data informing the selection of later-line treatment for patients with mCRC.

Chiara Cremolini, MD, PhD person default Teresa Macarulla, MD Released: December 20, 2021

Listen to Nilofer S. Azad, MD, and Kanwal Raghav, MD, as they discuss current and emerging uses of regorafenib and TAS-102 in later-line treatment of patients with mCRC.

Nilofer S. Azad, MD Kanwal Raghav, MD Released: April 6, 2022

Download this slideset for key insights from a podcast featuring an expert discussion of current and emerging uses of regorafenib and TAS-102 in later-line treatment of patients with mCRC.

Nilofer S. Azad, MD Kanwal Raghav, MD Released: April 6, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings